Fundraising Fox

Variant Pharmaceuticals

Weston, US · Founded 2014 · Florida corporation

Biotech

Founders & leadership

SC
Stephen C GloverExecutive

Board

NP
Nico PronkBoard director
SM
Shawn M TitcombBoard director

Reported raises · per SEC filings

Form D private placements

$8.1M disclosed across 6 of 7 rounds · 2014–2022

▶$419.3KraisedApr 2022 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Melda Uzbil O'ConnellExecutive Officer
  • Nick LaBellaExecutive Officer
  • Stephen GloverExecutive Officer, Director
  • Robert G FinizioDirector
  • Peter WolfeExecutive Officer
  • Minchul ParkDirector
  • Pablo GuzmanExecutive Officer
  • Karen CashmereExecutive Officer
Offering amount
$7M
Amount sold
$419.3K
Sales commissions
$560K
Placement agents
Noble Life Science Partners, Craft Capital Management LLC
First sale
Mar 2022
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedNov 2019 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert FinizioDirector
  • Anthony GiovinazzoDirector
  • Eric RichmanDirector
  • Andrew KimDirector
  • Aaron GreenblattDirector
  • Jules MusingDirector
  • Stephen C GloverExecutive Officer, Director
Offering amount
$20M
Amount sold
$1.3M
Sales commissions
$1.6M
Placement agents
Craft Capital Management LLC, Noble Life Science Partners
First sale
Oct 2019
Incorporated
Corporation, Florida
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedFeb 2018 · 20 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen C GloverExecutive Officer, Director
  • Jules MusingDirector
  • Aaron GreenblattDirector
Offering amount
$1.7M
Amount sold
$1.4M
First sale
Jan 2018
Incorporated
Corporation, Florida, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$525KraisedMar 2017 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nico PronkDirector
  • Aaron GreenblattDirector
  • Jules MusingDirector
  • Stephen C GloverExecutive Officer, Director
  • Shawn M TitcombDirector
Offering amount
$7M
Amount sold
$525K
Sales commissions
$490K
Placement agents
Noble Life Science Partners
First sale
Jan 2017
Incorporated
Corporation, Florida, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedOct 2016 · 21 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jules MusingDirector
  • Shawn M TitcombDirector
  • Nico PronkDirector
  • Stephen C GloverExecutive Officer, Director
  • Aaron GreenblattDirector
Offering amount
$4M
Amount sold
$1.5M
First sale
Mar 2016
Incorporated
Corporation, Florida, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MofferedJan 2016 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen C GloverExecutive Officer, Director
  • Shawn M TitcombDirector
  • Nico PronkDirector
  • Aaron GreenblattDirector
Offering amount
$25M
Sales commissions
$2M
Finders' fees
$80K
Placement agents
Craft Capital Management LLC, MIP Bahamas LTD
Incorporated
Corporation, Florida, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedFeb 2015 · 17 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nico PronkDirector
  • Stephen C GloverExecutive Officer, Director
  • Shawn M TitcombDirector
Offering amount
$3.5M
Amount sold
$3M
Minimum investment
$5K
Proceeds to insiders
$180K
First sale
Jul 2014
Incorporated
Corporation, Florida, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Variant Pharmaceuticals Secures $10 Million in Financing from Korean Company, Incon Co., Ltd.prnewswire.com · Dec 2018Craft Capital Management Closes 10 Million Dollar Transaction in Variant Pharmaceuticals, Inc. - BioSpacebiospace.com · Dec 2018

Frequently asked questions

How much funding has Variant Pharmaceuticals raised?
Variant Pharmaceuticals has disclosed $8.1M raised across 6 of its 7 known rounds.
Where is Variant Pharmaceuticals headquartered?
Variant Pharmaceuticals is headquartered in Weston, US.